Response to the Canadian Agency for Drugs and Technologies in Health and Institut national d'excellence en santé et en services sociaux decision regarding nusinersen for Spinal Muscular Atrophy

Affiliations

• ¹ 1Department of Pediatrics,Children's Hospital London Health Sciences Centre,Western University, London, Ontario,Canada.
• ² 2Division of Neurology, Department of Pediatrics, BC Children's Hospital, Vancouver, British Columbia,Canada.
• ³ 3Division of Neurology, Children's Hospital of Eastern Ontario, Ottawa, Ontario,Canada.
• ⁴ 4Department of Pediatrics, Hospital for Sick Children,University of Toronto, Toronto, Ontario,Canada.
• ⁵ 5Division of Neurology, Department of Clinical Neurosciences, Hotchkiss Brain Institute,University of Calgary, Calgary, Alberta,Canada.
• ⁶ 6Neurogenetics of Motion Laboratory, Montreal Neurological Institute,McGill University, Montreal, Quebec,Canada.
• ⁷ 7Apoptosis Research Centre, CHEO Research Institute, Department of Pediatrics,University of Ottawa, Ottawa, Ontario,Canada.
• ⁸ 8Department of Neurology and Neurosurgery,McGill University, Montreal, Quebec,Canada.